Compass Therapeutics Inc. (CMPX)
NASDAQ · Healthcare
Compass Therapeutics Inc. Operating Income 2023–2025
Compass Therapeutics Inc. annual/quarterly operating income history and growth rate from 2023 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Compass Therapeutics Inc. operating income for the quarter ending September 30, 2025 was -15.8 M, a 29.23% increase year-over-year.
- Compass Therapeutics Inc. operating income for the twelve months ending September 30, 2025 was -64.2 M.
- Compass Therapeutics Inc. annual operating income for 2025 was -72.8 M, a 28.63% increase from 2024.
- Compass Therapeutics Inc. annual operating income for 2024 was -56.6 M, a 12.43% increase from 2023.
- Compass Therapeutics Inc. annual operating income for 2023 was -50.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Compass Therapeutics Inc. Operating Income — FAQ
Compass Therapeutics Inc. (CMPX) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Compass Therapeutics Inc.'s operating income?
Compass Therapeutics Inc. (CMPX) reported operating income of -$73M for fiscal 2025.
Where can I see CMPX's operating income history?
The chart and table above show Compass Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.